Skip to main content

Health condition

CMT subtypes explained

Charcot-Marie-Tooth disease is not one condition but a family of inherited neuropathies - knowing your subtype guides prognosis, family advice and trial eligibility.

Key points

What matters most, at a glance.

The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.

  • CMT1 subtypes are demyelinating (slowed nerve conduction); CMT2 subtypes are axonal

  • CMT1A, caused by PMP22 duplication, is by far the most common subtype

  • X-linked CMT (CMTX1) affects men more severely and alters family risk advice

  • Nerve conduction studies plus a genetic panel identify the subtype in most families

  • Subtype matters for prognosis, inheritance pattern and eligibility for emerging clinical trials

Understanding it

About CMT subtypes explained, and what to do next.

All forms of CMT share the core picture - slowly progressive foot deformity, distal weakness and sensory loss - but the underlying genetics vary widely. CMT1 forms damage the myelin sheath and show markedly slowed conduction velocities; CMT2 forms damage the axon itself with relatively preserved velocities. CMT1A (PMP22 duplication) accounts for roughly half of all cases, while CMTX1 (GJB1) is the next most common and, being X-linked, affects men more severely than women.

Establishing the subtype starts with nerve conduction studies to classify demyelinating versus axonal, followed by targeted genetic testing or a multi-gene panel. The result shapes practical advice: inheritance risk for children, whether certain medications should be avoided, expected pace of progression, and whether emerging gene-targeted trials - several are underway for CMT1A - might apply. A neuromuscular clinic with genetic counselling support is the right setting, and a private consultation can be a faster route to testing where NHS neurology waits are long.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them.

Frequently asked

Common questions about CMT subtypes explained.

Quick, plain-English answers to what people ask us most.

  • What are the different subtypes of Charcot-Marie-Tooth disease?

    Charcot-Marie-Tooth disease (CMT) is divided into several main types based on the specific pattern of nerve damage and genetic cause: CMT1 (the most common, affecting the myelin coating of nerves), CMT2 (affecting the nerve fibre itself rather than myelin), CMT4 (rarer, more severe forms), and CMTX (X-linked forms), among others, with each type further divided into subtypes based on the specific gene involved. There are dozens of specific genetic subtypes identified in total. Identifying the specific subtype can help predict likely progression and inheritance pattern.

  • Why does the specific subtype matter?

    Different subtypes can vary in severity, typical age of onset, rate of progression, and inheritance pattern, so identifying the specific genetic subtype through testing can help provide more accurate information about expected disease course and, importantly, more precise genetic counselling for family planning. Some rarer subtypes are also more likely to be associated with additional features beyond the typical CMT symptoms. This detailed genetic information increasingly helps guide more personalised expectations and management.

  • How is the specific subtype identified?

    Identification is typically through genetic testing, which can now examine many known CMT-related genes simultaneously using modern testing panels, combined with nerve conduction studies that can help distinguish the general category (demyelinating versus axonal) even before genetic results are available. A specialist neurologist or genetic counsellor with experience in CMT can help interpret the combination of clinical and genetic findings. Not every case can be definitively subtyped, even with comprehensive testing, since new causative genes continue to be discovered.

  • Does the subtype affect treatment?

    Currently, most treatment approaches (physiotherapy, orthotics, and supportive management) are similar across subtypes, since there is no gene-specific treatment widely available yet for most forms of CMT. However, some research into subtype-specific treatments is progressing, and knowing your specific subtype may become more relevant as new treatments are developed. Genetic subtype information is also important for family counselling and, in the future, for any subtype-specific research or clinical trials that may become available.

  • Is genetic testing for CMT subtype always necessary?

    It's not strictly necessary for everyone, especially where the overall management plan wouldn't change based on the result, but it can be valuable for confirming the diagnosis with certainty, guiding genetic counselling for family members, and potentially informing entry into research studies or future subtype-specific treatments as they emerge. Discussing the pros and cons of testing with a genetic counsellor can help you decide if it's right for you and your family. It's ultimately a personal decision based on individual circumstances and priorities.

  • When should I see a specialist?

    If you have a diagnosis or suspected diagnosis of CMT and haven't had genetic subtyping, or want to discuss what a specific subtype result means for you and your family, a neurology or clinical genetics consultation can help. NHS genetics referral can take several weeks to months; a private consultation is typically available within about 2 weeks for earlier specialist assessment and explanation.